Search for Clinical Trial Results
Amyloidosis - 684 Studies Found
Status | Study |
Recruiting |
Study Name: Daratumumab Therapy for Patients With Refractory or Relapsed AL Amyloidosis Condition: Amyloidosis Date: 2016-06-22 Interventions: Drug: Daratumumab |
Recruiting |
Study Name: Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients With AL Amyloidosis Condition: Amyloidosis Date: 2014-09-15 Interventions: Drug: Chimeric Fibril-Reactive Monoclonal Anti-body 11-1F4 The antibody binds to the pathologic material |
Completed |
Study Name: Cyclophosphamide, Lenalidomide and Dexamethasone (CLD) for Previously Treated Patients With AL Amyloidosis Condition: Amyloidosis Date: 2008-01-22 Interventions:
|
Not yet recruiting |
Study Name: Propylene Glycol-Free Melphalan Hydrochloride (Evomela) in AL Amyloidosis Patients Condition: Amyloidosis; Systemic Date: 2016-11-18 Interventions: Drug: Propylene Glycol-Free Melphalan Hydrochloride Intravenous Propylene Glycol-Free Melphalan Hydrochl |
Completed |
Study Name: Intensive Versus Conventional Treatment in Patients With Primary Amyloidosis Condition: Primary Systemic Amyloidosis (AL) Date: 2006-06-22 Interventions:
|
Active, not recruiting |
Study Name: Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis Condition:
|
Completed |
Study Name: S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis Condition: Multiple Myeloma Date: 1999-11-01 Interventions:
|
Completed |
Study Name: CC-5013 With or Without Dexamethasone in Treating Patients With Primary Systemic Amyloidosis Condition: Multiple Myeloma Date: 2004-09-07 Interventions:
|
Suspended |
Study Name: Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis Condition: Primary Systemic Amyloidosis Date: 2005-09-21 Interventions: Drug: Enbrel |
Completed |
Study Name: Melphalan, Lenalidomide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis Condition: Multiple Myeloma Date: 2008-05-14 Interventions:
|